Adaptin Bio, Inc. Liquidation Value Calculator
Adaptin Bio, Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 87 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$1.51M | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$459,174 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$459,174 | USD | ||
| current_liabilities | ||||
| Accrued Liabilities Current total AccruedLiabilitiesCurrent |
$596,465 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$2.11M | USD | ||
| liabilities_total | ||||
| Liabilities total | $2.11M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
8.7M | shares | ||
Unmapped Tags (78)
| Additional Paid In Capital AdditionalPaidInCapital | $7.80M | USD | ||
| Assets Assets | $619,159 | USD | ||
| Assets Current AssetsCurrent | $619,159 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $50.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $8.66M | shares | ||
| Common Stock Value CommonStockValue | $866 | USD | ||
| Deferred Finance Costs Gross DeferredFinanceCostsGross | $197,570 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $2.02M | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $1.67M | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $2.02M | USD | ||
| Derivative Liabilities DerivativeLiabilities | $551,269 | USD | ||
| Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt | $326,345 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $619,159 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $10.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Prepaid Insurance PrepaidInsurance | $132,507 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-9.29M | USD | ||
| Stockholders Equity StockholdersEquity | $-1.49M | USD | ||
| Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense | $496,864 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | $425,089 | USD | ||
| Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Net DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet | $193,876 | USD | ||
| Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | $113,173 | USD | ||
| Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation | $1.02M | USD | ||
| Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | $2.46M | USD | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | $-453,445 | USD | ||
| Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade | $496,910 | USD | ||
| Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet | $14,190 | USD | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | $148,531 | USD | ||
| Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims | $250,000 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $5.20M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-4.78M | USD | ||
| Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts | $1.68M | USD | ||
| Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement | $7.16M | USD | ||
| Repayments Of Notes Payable RepaymentsOfNotesPayable | $275,000 | USD | ||
| Share Based Compensation ShareBasedCompensation | $496,864 | USD | ||
| Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | $2 | USD/shares | ||
| Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation | $496,864 | USD | ||
| Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment | $236,213 | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-1 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-1 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments | $0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $3.64M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $-5.17M | USD | ||
| Income Taxes Paid IncomeTaxesPaid | $0 | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $1.11M | USD | ||
| Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | $-1.09M | USD | ||
| Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments | $40,334 | USD | ||
| Interest Expense Nonoperating InterestExpenseNonoperating | $72,659 | USD | ||
| Net Income Loss NetIncomeLoss | $-5.17M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $247,374 | USD | ||
| Operating Expenses OperatingExpenses | $5.41M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-5.41M | USD | ||
| Other General And Administrative Expense OtherGeneralAndAdministrativeExpense | $180,000 | USD | ||
| Other Prepaid Expense Current OtherPrepaidExpenseCurrent | $5,000 | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $159,985 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $1.77M | USD | ||
| Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts | $53,722 | USD | ||
| Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts | $1.68M | USD | ||
| Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | $132,570 | shares | ||
| Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding | $2.61M | shares | ||
| Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1 | $501,140 | shares | ||
| Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet | $-6,312 | USD | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $6,312 | USD | ||
| Interest Paid Net InterestPaidNet | $9,584 | USD | ||
| Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices | $250,000 | USD | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $5.28M | USD | ||
| Unrecognized Tax Benefits UnrecognizedTaxBenefits | $112,155 | USD | ||
| CommonStockConvertibleConversionPriceIncrease CommonStockConvertibleConversionPriceIncrease | $3 | USD/shares | ||
| WarrantExercisePriceDecrease WarrantExercisePriceDecrease | $3 | USD/shares | ||
| WarrantExercisePriceIncrease WarrantExercisePriceIncrease | $4 | USD/shares |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.